CanLyme welcomes Dr. Vett Lloyd
Professor, researcher and Lyme disease advocate.
CanLyme: 20 years of Canadian advocacy
Looking back at two decades of advocacy and education; looking forward to the road ahead.
Protein found in human sweat inhibits growth of Lyme bacteria
Satu Strausz of Finland leads international group exploring biobank, in vitro, and murine research.
Diagnosis and treatment of Lyme carditis
Understanding the risks, manifestations and clinical management of Lyme carditis can save lives and prevent invasive medical and surgical interventions.
Persistence of Lyme patients and the role of patient organizations
This in-depth article by Cox and Levesque gives context to many of the systemic barriers that Canadian Lyme patients encounter, and highlights the important role that patient organizations play in addressing those barriers.
Medical Gaslighting and Lyme Disease: The Patient Experience
Published December 29, 2023 in Healthcare Authored by Jennifer L. Fagen, Jeremy A. Shelton, Jenna Luché-Thayer Abstract: Even though there are approximately half a million new cases of Lyme disease in the US annually, according to the CDC, it is often undiagnosed or misdiagnosed, which can result in a chronic, multisystemic condition. Lyme disease is…
Leaning into 2024
This work can save lives. You can keep helping us.
- For Physicians | Government | International Support Other Than Canada | Lyme Controversy | Voices on Lyme
Lack of effective healthcare for Canadian Lyme patients and why they turn elsewhere
In response to an article about Amélie Champagne’s inquiry.
Are you planning to travel?
Being aware of ticks and tick-borne illnesses can help prevent serious health problems at home and away.
Spark hope this Giving Tuesday: Your chance to create change!
This Giving Tuesday, show your support for the Canadian Lyme Disease Foundation. Let’s ignite a spark of hope together. Your generosity has the power to make a significant impact in the lives of those affected by Lyme disease and contribute to ongoing efforts in research, education, advocacy and support to address this health challenge in…
French subtitled online viewing – The Quiet Epidemic
Visionnement en ligne- The quiet epidemic.
Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness
Examining serology and the health burden of Lyme disease and chronic illness with Victoria Sanderson at the G Magnotta Lab.
Lyme Carditis from A to Z: A new book by Dr. Adrian Baranchuk
Dr. Baranchuk is a full professor at Queen’s University and has published over 750 articles in well-recognized journals.
Whole genome sequencing of human Borrelia burgdorferi isolates reveals linked blocks of accessory genome elements located on plasmids and associated with human dissemination
Using genetic association study methods, we identify an accessory genome signature associated with dissemination in humans and define the individual plasmids and genes that make up this signature.
- Education | For Physicians | Lyme Controversy | Lyme disease | Medical Publications | Miscellaneous | Research
Children are more than twice as likely to lose their detectable antibodies to Lyme disease bacteria
Background Lyme borreliosis (LB), caused by Borrelia burgdorferi (Bb), is the most common tick-borne infection in Germany. Antibodies against Bb are prevalent in the general population but information on temporal changes of prevalence and estimates of seroconversion (seroincidence) and seroreversion are lacking, especially for children and adolescents. Aim We aimed at assessing antibodies against Bb and factors associated with seropositivity…
